Xiaonan Hou
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Reproductive Medicine top 2%
- Immunology top 10%
- Co-authors
- S. John WerohaSanjoy K. DasPaul HaluskaSudhansu K. DeyMeiling LiYi TanSean C. DowdyMarco M. Gottardis
- Topics
- Ovarian cancer diagnosis and treatment (18 papers)PARP inhibition in cancer therapy (11 papers)Epigenetics and DNA Methylation (8 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Xiaonan Hou
65 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 139
- Molecular Biology 963
- Oncology 553
- Cancer Research 337
- Reproductive Medicine 295
- Immunology 219
Countries citing papers authored by Xiaonan Hou
This map shows the geographic impact of Xiaonan Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaonan Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaonan Hou more than expected).
Fields of papers citing papers by Xiaonan Hou
This network shows the impact of papers produced by Xiaonan Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaonan Hou. The network helps show where Xiaonan Hou may publish in the future.
Co-authorship network of co-authors of Xiaonan Hou
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaonan Hou. A scholar is included among the top collaborators of Xiaonan Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaonan Hou. Xiaonan Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 22 | |
| 5 | 36 | |
| 6 | 14 | |
| 7 | 48 | |
| 8 | 76 | |
| 9 | 31 | |
| 10 | 60 | |
| 11 | 45 | |
| 12 | The Role of Microbiota in Human Reproductive Tract Cancers | 3 |
| 13 | 32 | |
| 14 | Loss of RAD51C promoter hypermethylation confers PARP inhibitor resistance | 1 |
| 15 | 31 | |
| 16 | 47 | |
| 17 | 7 | |
| 18 | 28 | |
| 19 | 63 | |
| 20 | 16 |
About Xiaonan Hou
Xiaonan Hou is a scholar working on Reproductive Medicine, Oncology and Molecular Biology, having authored 73 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (18 papers), PARP inhibition in cancer therapy (11 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Reproductive Medicine (295 citations), Cancer Research (337 citations) and Oncology (553 citations). Xiaonan Hou has collaborated with scholars based in United States, China and Germany. Frequent co-authors include S. John Weroha, Sanjoy K. Das, Paul Haluska, Sudhansu K. Dey, Meiling Li, Yi Tan, Sean C. Dowdy, Marco M. Gottardis, Joan M. Carboni and Saravut J. Weroha. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.